Endomag Outlines Commercial Ambitions Following Landmark FDA Approval
Executive Summary
Endomag is making plans to shake up the US breast cancer market with its Sentimag and Magtrace combination breast cancer system, which recently earned US FDA approval. The company recently raised $10m to scale its commercial operations.